Dr. Kadir Erkmen, MD

Dr. Erkmen practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Erkmen's NPI, 1790888345, was assigned on September 7, 2006. Dr. Erkmen graduated from University of Maryland School of Medicine - Baltimore in 1997. Dr. Erkmen holds Pennsylvania license MD451032.

Dr. Erkmen's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Erkmen's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Erkmen is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Erkmen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erkmen practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Erkmen's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Erkmen is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Erkmen's licenses on file in 4 states: Pennsylvania, New Hampshire, Massachusetts and Arkansas.

Dmand AI lists craniotomy among the conditions Dr. Erkmen treats.

CMS data shows 42 Medicare services from Dr. Erkmen across 2 procedure codes in 2024, for 50 Medicare patients. Medicare paid $1,789 for them.

CMS counts 50 Medicare patients who saw Dr. Erkmen in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erkmen's median patient age at 67, with 60% women.

In 2022, Dr. Erkmen wrote 17 Medicare Part D claims. They cover 1 drug, with $58 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Erkmen for performance year 2024, reported as part of a group. Dr. Erkmen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 41 papers to Dr. Erkmen, published from 2005 to 2025. 2012 was the busiest year, with 7. The most frequent topics are Neurosurgical Procedures, Magnetic Resonance Imaging and Meningeal Neoplasms. Dr. Erkmen has published most often in J Neurosurg. Dr. Erkmen's most frequent co-authors are Kimon Bekelis, MD, Atman Mukesh Desai, MD and Nathan Eric Simmons, MD.

Dmand AI links Dr. Erkmen to 1 clinical trial. Conditions studied include Stroke and Cerebrovascular Disorders.

CMS Open Payments shows 54 general payments to Dr. Erkmen from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 69% of the total. Stryker Corporation paid the most, $2,509.

Dmand AI lists 4 awards for Dr. Erkmen, most recently Philadelphia Magazine Top Doctors in 2016.

Dr. Erkmen graduated from University of Maryland School of Medicine - Baltimore in 1997. Dr. Erkmen is a member of AOA, AANS, AHA and CNS.

Dr. Erkmen is in network with 12 carriers, including Aetna, Elevance and Highmark. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.